What is Wegovy? Uses, doses, pill and pen, and cost
The short answer
Wegovy is semaglutide, a GLP-1 medicine from Novo Nordisk that comes as a once-weekly injection and a once-daily tablet. The FDA label approves it for long-term weight reduction in adults with obesity, or with overweight and at least one weight-related condition, and for lowering cardiovascular risk in adults with established cardiovascular disease and obesity or overweight. The lowest self-pay price is $149 a month for the 1.5 mg tablet through NovoCare Pharmacy.
Key takeaways
- Wegovy comes as a once-weekly pen or a once-daily pill, and each has its own dose steps.
- Paying cash? The lowest self-pay price is $149 a month for the 1.5 mg tablet through NovoCare Pharmacy.
- The pill has strict rules: morning, empty stomach, up to 4 ounces of water, then wait at least 30 minutes.
- If you miss 2 or more weekly doses in a row, ask your prescriber where to restart.
- On Medicare? For weight management, eligible Part D patients can get the pen or pill through the GLP-1 Bridge for a $50 monthly copay.
On this page
- What is Wegovy used for?
- What forms does Wegovy come in?
- What doses does Wegovy come in?
- How do you take Wegovy?
- How well does Wegovy work for weight loss?
- How much does Wegovy cost?
- Does insurance or Medicare cover Wegovy?
- What are the side effects of Wegovy?
- What if I miss a dose of Wegovy?
- How do I store Wegovy?
- Can I switch between the Wegovy pen and the pill?
- Frequently asked questions
- Sources
Wegovy at a glance
| Active ingredient | semaglutide |
|---|---|
| Maker | Novo Nordisk |
| FDA-approved uses |
|
| Forms and strengths |
|
| Medicare GLP-1 Bridge | Covered forms: Single-dose pen (7.2 mg pen is branded WEGOVY HD); Tablet (once daily) |
| Cheapest verified self-pay | $299 per fill at 25 mg, NovoCare self-pay (novocare.com) |
| With commercial insurance that covers it | $25 per fill at 25 mg, Manufacturer savings card (wegovy.com) |
| On Medicare Part D | $50 per fill at 25 mg, Medicare GLP-1 Bridge (medicare.gov) |
| Label | Revised: 6/2026 (DailyMed version 19) |
Wegovy dose schedule from the label
Single-dose pen (7.2 mg pen is branded WEGOVY HD)Revised: 6/2026 (DailyMed version 19)
Tablet (once daily)Revised: 6/2026 (DailyMed version 19)
Put it on a calendar with the titration schedule builder. Only your prescriber decides when, and whether, your dose changes.
See every price
Every verified Wegovy price
| Where you buy | Form · dose | Price | Conditions | Source |
|---|---|---|---|---|
| Medicare GLP-1 Bridge | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · All strengths | $50/month | ConditionsMedicare GLP-1 Bridge demonstration, July 1, 2026 through December 31, 2027. For adults 18 or older with Medicare Part D drug coverage (standalone PDP, MA-PD, SNP, EGWP or LI NET) who meet the BMI criteria when starting GLP-1 therapy (BMI 35+, or BMI 30+ with diastolic heart failure, uncontrolled hypertension or CKD stage 3a+, or BMI 27+ with prediabetes, prior heart attack or stroke, or symptomatic peripheral artery disease). Not for people already getting GLP-1s through their Part D plan, or using the drug for type 2 diabetes, sleep apnea or fatty liver disease. Prior authorization required (valid through December 31, 2027 unless you change drugs). $50 copay per one-month supply (28 or 30 days); it does not count toward the Part D deductible or out-of-pocket limit and cannot be reduced by Extra Help. Wegovy is covered as both the injection (pen) and the tablet at all strengths. | medicare.gov |
| Medicare GLP-1 Bridge | Tablet (once daily) · All strengths | $50/month | ConditionsMedicare GLP-1 Bridge demonstration, July 1, 2026 through December 31, 2027. For adults 18 or older with Medicare Part D drug coverage (standalone PDP, MA-PD, SNP, EGWP or LI NET) who meet the BMI criteria when starting GLP-1 therapy (BMI 35+, or BMI 30+ with diastolic heart failure, uncontrolled hypertension or CKD stage 3a+, or BMI 27+ with prediabetes, prior heart attack or stroke, or symptomatic peripheral artery disease). Not for people already getting GLP-1s through their Part D plan, or using the drug for type 2 diabetes, sleep apnea or fatty liver disease. Prior authorization required (valid through December 31, 2027 unless you change drugs). $50 copay per one-month supply (28 or 30 days); it does not count toward the Part D deductible or out-of-pocket limit and cannot be reduced by Extra Help. Wegovy is covered as both the injection (pen) and the tablet at all strengths. | medicare.gov |
| Manufacturer savings card | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · All strengths | $25/month | ConditionsCommercial insurance that covers Wegovy. Pay as little as $25 per month, subject to a maximum savings of $100 per month. Month is one box of 4 pens. Government beneficiaries excluded. Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program at any time. | wegovy.com |
| Manufacturer savings card | Tablet (once daily) · All strengths | $25/month | ConditionsCommercial insurance that covers Wegovy. Pay as little as $25 per month, subject to a maximum savings of $100 per month. Month is one bottle of 30 tablets. Government beneficiaries excluded. Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program at any time. | wegovy.com |
| TrumpRx | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · 0.25 mg | $199/month | ConditionsOut-of-pocket (self-pay) price on TrumpRx.gov. New patients pay $199 for the first two monthly fills of 0.25 mg or 0.5 mg (fills between 11/17/2025 and 12/31/2026), then $349 per month. Self-pay only; government beneficiaries excluded; no insurance reimbursement. | trumprx.gov |
| TrumpRx | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · 0.5 mg | $199/month | ConditionsOut-of-pocket (self-pay) price on TrumpRx.gov. New patients pay $199 for the first two monthly fills of 0.25 mg or 0.5 mg (fills between 11/17/2025 and 12/31/2026), then $349 per month. Self-pay only; government beneficiaries excluded; no insurance reimbursement. | trumprx.gov |
| TrumpRx | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · 1 mg | $349/month | ConditionsOut-of-pocket (self-pay) price on TrumpRx.gov for one month (one pen box). Self-pay only; government beneficiaries excluded; no insurance reimbursement. TrumpRx lists the original price as $1,349.02. | trumprx.gov |
| TrumpRx | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · 1.7 mg | $349/month | ConditionsOut-of-pocket (self-pay) price on TrumpRx.gov for one month (one pen box). Self-pay only; government beneficiaries excluded; no insurance reimbursement. TrumpRx lists the original price as $1,349.02. | trumprx.gov |
| TrumpRx | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · 2.4 mg | $349/month | ConditionsOut-of-pocket (self-pay) price on TrumpRx.gov for one month (one pen box). Self-pay only; government beneficiaries excluded; no insurance reimbursement. TrumpRx lists the original price as $1,349.02. | trumprx.gov |
| TrumpRx | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · 7.2 mg | $399/month | ConditionsOut-of-pocket (self-pay) price on TrumpRx.gov for one month (one pen box). This is the Wegovy HD 7.2 mg pen. Self-pay only; government beneficiaries excluded; no insurance reimbursement. TrumpRx lists the original price as $1,349.02. | trumprx.gov |
| TrumpRx | Tablet (once daily) · 1.5 mg | $149/month | ConditionsOut-of-pocket (self-pay) price on TrumpRx.gov for 30 tablets, redeemed with a coupon at a retail pharmacy. Self-pay patients only; government beneficiaries excluded; you may not seek insurance reimbursement. TrumpRx lists the original price as $1,349.02. | trumprx.gov |
| TrumpRx | Tablet (once daily) · 4 mg | $199/month | ConditionsOut-of-pocket (self-pay) price on TrumpRx.gov for 30 tablets, redeemed with a coupon at a retail pharmacy. Self-pay patients only; government beneficiaries excluded; you may not seek insurance reimbursement. TrumpRx lists the original price as $1,349.02. | trumprx.gov |
| TrumpRx | Tablet (once daily) · 9 mg | $299/month | ConditionsOut-of-pocket (self-pay) price on TrumpRx.gov for 30 tablets, redeemed with a coupon at a retail pharmacy. Self-pay patients only; government beneficiaries excluded; you may not seek insurance reimbursement. TrumpRx lists the original price as $1,349.02. | trumprx.gov |
| TrumpRx | Tablet (once daily) · 25 mg | $299/month | ConditionsOut-of-pocket (self-pay) price on TrumpRx.gov for 30 tablets, redeemed with a coupon at a retail pharmacy. Self-pay patients only; government beneficiaries excluded; you may not seek insurance reimbursement. TrumpRx lists the original price as $1,349.02. | trumprx.gov |
| NovoCare self-pay | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · 0.25 mg | $199/month | ConditionsLimited-time introductory self-pay price for patients new to the Wegovy Savings Offer or NovoCare Pharmacy: $199 per month for up to 2 monthly fills of 0.25 mg or 0.5 mg through December 31, 2026, then $349 per month. One month is one box of 4 pens. No insurance used; eligibility and restrictions apply. | novocare.com |
| NovoCare self-pay | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · 0.5 mg | $199/month | ConditionsLimited-time introductory self-pay price for patients new to the Wegovy Savings Offer or NovoCare Pharmacy: $199 per month for up to 2 monthly fills of 0.25 mg or 0.5 mg through December 31, 2026, then $349 per month. One month is one box of 4 pens. No insurance used; eligibility and restrictions apply. | novocare.com |
| NovoCare self-pay | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · 1 mg | $349/month | ConditionsSelf-pay price through NovoCare Pharmacy or the Wegovy self-pay offer at a retail pharmacy; no insurance used. One month is one box of 4 pens. Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program at any time. | novocare.com |
| NovoCare self-pay | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · 1.7 mg | $349/month | ConditionsSelf-pay price through NovoCare Pharmacy or the Wegovy self-pay offer at a retail pharmacy; no insurance used. One month is one box of 4 pens. Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program at any time. | novocare.com |
| NovoCare self-pay | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · 2.4 mg | $349/month | ConditionsSelf-pay price through NovoCare Pharmacy or the Wegovy self-pay offer at a retail pharmacy; no insurance used. One month is one box of 4 pens. Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program at any time. | novocare.com |
| NovoCare self-pay | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · 7.2 mg | $399/month | ConditionsSelf-pay price through NovoCare Pharmacy or the Wegovy self-pay offer at a retail pharmacy; no insurance used. This is the Wegovy HD 7.2 mg pen. One month is one box of 4 pens. Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program at any time. | novocare.com |
| NovoCare self-pay | Tablet (once daily) · 1.5 mg | $149/month | ConditionsSelf-pay price through NovoCare Pharmacy (home delivery) or with the Wegovy self-pay offer at a retail pharmacy; no insurance used. One month is one bottle of 30 tablets. Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program at any time. | novocare.com |
| NovoCare self-pay | Tablet (once daily) · 4 mg | $199/month | ConditionsSelf-pay price through NovoCare Pharmacy (home delivery) or with the Wegovy self-pay offer at a retail pharmacy; no insurance used. One month is one bottle of 30 tablets. Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program at any time. | novocare.com |
| NovoCare self-pay | Tablet (once daily) · 9 mg | $299/month | ConditionsSelf-pay price through NovoCare Pharmacy (home delivery) or with the Wegovy self-pay offer at a retail pharmacy; no insurance used. One month is one bottle of 30 tablets. Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program at any time. | novocare.com |
| NovoCare self-pay | Tablet (once daily) · 25 mg | $299/month | ConditionsSelf-pay price through NovoCare Pharmacy (home delivery) or with the Wegovy self-pay offer at a retail pharmacy; no insurance used. One month is one bottle of 30 tablets. Eligibility and restrictions apply; Novo Nordisk may modify or cancel the program at any time. | novocare.com |
| Hims & Hers | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · All strengths | $199/month | Conditions'From' price; medication only. Requires Hims Weight Loss Membership ($39 first month, then $149/month), billed separately. Cash-pay; insurance not required. Not available in all 50 states. | hims.com |
| LifeMD | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · All strengths | $199/month | Conditions'Starting at' price, cash-pay. Plus LifeMD program fee ($39 first month, then $149/month). With insurance the page advertises copays as low as $25. | lifemd.com |
| Measured | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · All strengths | $199/month | ConditionsLow end of the range shown; medication priced separately from membership (homepage 'Membership from $49/mo'; Zepbound page shows $99/mo). Range $199-$349/mo, covered by insurance or cash pay. | trymeasured.com |
| Mochi Health | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · All strengths | $199/month | Conditions'As low as' price; plus Mochi Health membership ($79/month, first month $0 promo for new subscribers). Medication not included in membership; availability and pricing vary by state. | joinmochi.com |
| Sesame | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · All strengths | $349/month | ConditionsManufacturer self-pay price passed through by Sesame ('No markups on medication'); plus Success by Sesame subscription ($99/mo month-to-month, as low as $59/mo annual). Standard price after the two-month introductory period, all doses 0.25-2.4 mg. | sesamecare.com |
| Eden | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · All strengths | $1,695/month | ConditionsSame price at every dose. Medication only; requires Eden Membership ($39 first month, auto-renews at $99/month). Cash-pay; Eden does not take insurance. | eden.health |
| Ro | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · 0.25 mg | $199/month | ConditionsPlus Ro Body membership ($39 first month, then $149/mo monthly or $74/mo prepaid annually). Cash-pay; Ro states prices match LillyDirect, NovoCare and TrumpRx. Limited-time offer for the first two months only (regular $349); valid for 0.25 mg and 0.5 mg; sign up by Dec 31, 2026. | ro.co |
| Sesame | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · 0.25 mg | $199/month | ConditionsManufacturer self-pay price passed through by Sesame ('No markups on medication'); plus Success by Sesame subscription ($99/mo month-to-month, as low as $59/mo annual). New self-pay patients only, first two consecutive months, offer valid Nov 17, 2025 - Dec 31, 2026; then $349/month. | sesamecare.com |
| Ro | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · 0.5 mg | $199/month | ConditionsPlus Ro Body membership ($39 first month, then $149/mo monthly or $74/mo prepaid annually). Cash-pay; Ro states prices match LillyDirect, NovoCare and TrumpRx. Limited-time offer for the first two months only (regular $349); valid for 0.25 mg and 0.5 mg; sign up by Dec 31, 2026. | ro.co |
| Sesame | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · 0.5 mg | $199/month | ConditionsManufacturer self-pay price passed through by Sesame ('No markups on medication'); plus Success by Sesame subscription ($99/mo month-to-month, as low as $59/mo annual). New self-pay patients only, first two consecutive months, offer valid Nov 17, 2025 - Dec 31, 2026; then $349/month. | sesamecare.com |
| Ro | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · 1 mg | $349/month | ConditionsPlus Ro Body membership ($39 first month, then $149/mo monthly or $74/mo prepaid annually). Cash-pay; Ro states prices match LillyDirect, NovoCare and TrumpRx. Weekly semaglutide injection. | ro.co |
| Ro | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · 1.7 mg | $349/month | ConditionsPlus Ro Body membership ($39 first month, then $149/mo monthly or $74/mo prepaid annually). Cash-pay; Ro states prices match LillyDirect, NovoCare and TrumpRx. Weekly semaglutide injection. | ro.co |
| Ro | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · 2.4 mg | $349/month | ConditionsPlus Ro Body membership ($39 first month, then $149/mo monthly or $74/mo prepaid annually). Cash-pay; Ro states prices match LillyDirect, NovoCare and TrumpRx. Weekly semaglutide injection. | ro.co |
| Ro | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · 7.2 mg | $399/month | ConditionsPlus Ro Body membership ($39 first month, then $149/mo monthly or $74/mo prepaid annually). Cash-pay; Ro states prices match LillyDirect, NovoCare and TrumpRx. Wegovy HD. | ro.co |
| Hims & Hers | Tablet (once daily) · All strengths | $149/month | Conditions'From' price; medication only. Requires Hims Weight Loss Membership ($39 first month, then $149/month), billed separately. Cash-pay; insurance not required. Not available in all 50 states. | hims.com |
| Measured | Tablet (once daily) · All strengths | $149/month | ConditionsLow end of the range shown; medication priced separately from membership (homepage 'Membership from $49/mo'; Zepbound page shows $99/mo). Range $149-$299/mo; no insurance needed. | trymeasured.com |
| Mochi Health | Tablet (once daily) · All strengths | $149/month | Conditions'As low as' price; plus Mochi Health membership ($79/month, first month $0 promo for new subscribers). Medication not included in membership; availability and pricing vary by state. | joinmochi.com |
| Ro | Tablet (once daily) · 1.5 mg | $149/month | ConditionsPlus Ro Body membership ($39 first month, then $149/mo monthly or $74/mo prepaid annually). Cash-pay; Ro states prices match LillyDirect, NovoCare and TrumpRx. Daily semaglutide tablet. | ro.co |
| Ro | Tablet (once daily) · 4 mg | $199/month | ConditionsPlus Ro Body membership ($39 first month, then $149/mo monthly or $74/mo prepaid annually). Cash-pay; Ro states prices match LillyDirect, NovoCare and TrumpRx. Daily semaglutide tablet. | ro.co |
| Ro | Tablet (once daily) · 9 mg | $299/month | ConditionsPlus Ro Body membership ($39 first month, then $149/mo monthly or $74/mo prepaid annually). Cash-pay; Ro states prices match LillyDirect, NovoCare and TrumpRx. Daily semaglutide tablet. | ro.co |
| Ro | Tablet (once daily) · 25 mg | $299/month | ConditionsPlus Ro Body membership ($39 first month, then $149/mo monthly or $74/mo prepaid annually). Cash-pay; Ro states prices match LillyDirect, NovoCare and TrumpRx. Daily semaglutide tablet. | ro.co |
| List price | Single-dose pen (7.2 mg pen is branded WEGOVY HD) · All strengths | $1,349.02/fill | ConditionsList price per package as stated by Novo Nordisk (one box of 4 pens; the same figure is stated for the Wegovy HD 7.2 mg pen). Novo Nordisk has announced a lower $675 list price effective January 1, 2027. | novocare.com |
| List price | Tablet (once daily) · All strengths | $1,349.02/fill | ConditionsList price per package as stated by Novo Nordisk (one bottle of 30 tablets). Novo Nordisk has announced a lower $675 list price effective January 1, 2027. | novocare.com |
Wegovy is the brand name Novo Nordisk uses for semaglutide when it’s prescribed for weight and cardiovascular risk. It’s a GLP-1 receptor agonist, and it comes in two very different forms: a pen you inject once a week and a tablet you swallow once a day. This guide covers what the FDA label (Revised: 6/2026 (DailyMed version 19)) says about each one, and what each one costs. Every price on this page comes from our price records, which also feed the cost calculator.
What is Wegovy used for?
The label lists three kinds of use, and they don’t all apply to both forms.
- Weight reduction. The injection is approved to reduce excess body weight and keep it off long term in adults and in pediatric patients aged 12 and older with obesity, and in adults with overweight who have at least one weight-related condition. The tablets are approved for adults with obesity, and for adults with overweight and at least one weight-related condition.
- Cardiovascular risk. Both the injection and the tablets are approved to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight.
- MASH. Only the injection is approved, under accelerated approval, to treat noncirrhotic MASH (a liver disease, here in people without cirrhosis) with moderate to advanced liver fibrosis, or scarring (stages F2 to F3), in adults.
The label also limits how Wegovy is used: taking it together with other semaglutide products, or with any other GLP-1 receptor agonist, isn’t recommended. That includes Ozempic and Rybelsus, which both contain semaglutide.
Wegovy for heart disease
The cardiovascular approval rests on an outcomes trial of 17,604 adults followed for a median of 41.8 months. Wegovy injection reduced the risk of a first major adverse cardiovascular event, with a hazard ratio of 0.80. (A hazard ratio compares risk between two groups.) Events occurred in 6.5% of patients on Wegovy and 8% on placebo. This use matters for coverage too, as the Medicare section below explains.
Wegovy for MASH
In the label’s MASH trial, adults with stage 2 or 3 fibrosis were assessed by liver biopsy at week 72. Steatohepatitis (the liver inflammation in MASH) resolved without fibrosis getting worse in 63% of patients on Wegovy injection and 34% on placebo. Fibrosis improved without steatohepatitis getting worse in 37% and 22%. The approval is an accelerated one, and it applies to the injection, not the tablets.
What forms does Wegovy come in?
There are two forms on the market that we track, and the label describes a third device.
The single-dose pen comes in strengths of 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg, 7.2 mg. You use each pen one time only. A carton holds 4 pens, which is a 28-day supply. The 7.2 mg pen is sold under the name Wegovy HD.
The tablet, often called the Wegovy pill, comes in strengths of 1.5 mg, 4 mg, 9 mg, 25 mg. A bottle holds 30 tablets, a 30-day supply.
The label also lists cartons of 4 single-dose syringes and a single-patient-use pen called Wegovy FlexTouch. The prices below are for the single-dose pen and the tablets.
If you’re choosing between forms, the pen vs vial vs pill comparer puts the per-fill costs side by side.
What doses does Wegovy come in?
Both forms start low and step up, which the label says is done to reduce the risk of gastrointestinal (stomach and bowel) side effects. The dose ladder above shows every step, and the titration schedule tool turns it into calendar dates.
When to increase your Wegovy dose
For the injection, the label’s schedule moves up every 4 weeks. You start at 0.25 mg once weekly for weeks 1 through 4, then take 0.5 mg for weeks 5 through 8, 1 mg for weeks 9 through 12 and 1.7 mg for weeks 13 through 16. If you don’t tolerate a dose, the label says to consider delaying the increase for 4 weeks. Your prescriber decides the timing of each step.
Wegovy 2.4 mg
The label calls 2.4 mg once weekly the usual recommended maintenance dosage (the dose you stay on), reached from week 17 onward. It’s the maintenance dosage for every approved use. For weight reduction in adults, the label names 1.7 mg as an alternative maintenance dosage, with 2.4 mg recommended.
Wegovy 7.2 mg (Wegovy HD)
The 7.2 mg dose is optional and narrow. The label allows an increase to 7.2 mg once weekly only for adults who are taking Wegovy for weight reduction, have tolerated 2.4 mg for at least 4 weeks, and for whom additional weight reduction is clinically indicated. It’s the maximum dosage. It isn’t a maintenance option for cardiovascular risk reduction, for pediatric patients or for MASH.
Wegovy pill doses
The tablets follow their own schedule in 30-day steps: 1.5 mg once daily for days 1 through 30, 4 mg for days 31 through 60, 9 mg for days 61 through 90, and the 25 mg maintenance dosage from day 91. If you don’t tolerate 25 mg, the label says a switch to the 1.7 mg weekly injection can be considered.
How do you take Wegovy?
The weekly injection
You inject Wegovy once a week, on the same day each week, at any time of day, with or without meals. It goes under the skin of your abdomen, thigh or upper arm. The label says to rotate injection sites with each dose, and that you can change the time of day and the site without any change to the dose. If you need to move your weekly day, the Medication Guide allows it as long as your last dose was given 2 or more days before.
How to take the Wegovy pill
The tablet has stricter rules than the pen, because food and drink interfere with it. The label’s instructions are:
- Take one tablet once daily, in the morning, on an empty stomach.
- Take it with water only, up to 4 ounces. No other liquid.
- Swallow the tablet whole. Don’t split, crush, chew or dissolve it.
- Wait at least 30 minutes before you eat, drink other beverages or take other oral medicines.
- Don’t take more than one tablet per day.
Can I take the Wegovy pill at night?
The label doesn’t offer a night-time option. Its only timing instruction is once daily, in the morning, on an empty stomach, followed by the 30-minute wait. If a morning routine is hard to keep, talk to your prescriber or pharmacist.
How well does Wegovy work for weight loss?
The label reports results from separate trials, and each figure belongs to its own trial population.
- Injection, 2.4 mg. In Study 2, a 68-week trial in adults with obesity or overweight and without diabetes, mean (average) body weight fell 14.9% with Wegovy 2.4 mg and 2.4% with placebo, a difference of 12.4%.
- Tablets, 25 mg. In Study 7, a 64-week trial in adults without diabetes, mean body weight fell 13.6% with the 25 mg tablets and 2.4% with placebo, a difference of 11.2%.
- Wegovy HD, 7.2 mg. In Study 8, a 72-week trial in adults with obesity, mean body weight fell 18.8% with 7.2 mg, 15.5% with 2.4 mg and 3.9% with placebo.
These are averages across a trial, with diet and activity counseling in the background. They aren’t a forecast for one person, and the injection and tablet trials weren’t run against each other.
How much does Wegovy cost?
What you pay depends on whether you use insurance, and on the form and dose. The prices are:
- Tablets, self-pay. $149 a month for 1.5 mg, $199 for 4 mg, and $299 for 9 mg and 25 mg, through NovoCare Pharmacy or the self-pay offer at a retail pharmacy.
- Pen, self-pay. $349 a month for 1 mg, 1.7 mg and 2.4 mg, and $399 for the 7.2 mg Wegovy HD pen. If you’re new to the offer, you pay $199 a month for up to two monthly fills of 0.25 mg or 0.5 mg through December 31, 2026, then $349.
- Commercial insurance that covers Wegovy. The savings offer brings a fill to as little as $25 a month, with a cap on how much Novo Nordisk pays per fill. If you have government insurance, you can’t use it.
- List price. $1,349.02 per package for the pen, the HD pen and the tablets. This is the full price before any discount. Novo Nordisk has announced a lower list price effective January 1, 2027.
TrumpRx lists the same self-pay prices and issues a coupon to use at a retail pharmacy. It’s a price-listing site, not a pharmacy.
Prices differ because they’re different programs with different rules. Self-pay means you don’t use insurance and can’t ask a plan to reimburse you. The savings offer works only on top of commercial coverage. The full breakdown, including what a year adds up to, is on the Wegovy cost page. For the wider picture, see our guides to GLP-1 costs and paying without insurance.
Does insurance or Medicare cover Wegovy?
Commercial plans vary. Many require prior authorization (the plan’s approval before it pays), and some exclude weight-management drugs entirely. Call the number on your insurance card and ask whether Wegovy is on the formulary (the plan’s list of covered drugs) for your diagnosis. If you’re denied, the appeal letter generator drafts a request you can take to your prescriber.
Medicare is more specific. CMS says Medicare and Medicaid generally do not cover GLP-1 drugs for the weight loss indication. There are two routes around that for Wegovy:
- Part D, for a covered use. CMS names Wegovy prescribed to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and obesity or overweight as a use that is coverable under the basic Part D benefit. Noncirrhotic MASH with moderate to advanced fibrosis is also an indication CMS lists as eligible for Part D coverage.
- The Medicare GLP-1 Bridge, for weight management. Eligible Part D patients can get the Wegovy pen or pill for a $50 copay per one-month supply, from July 1, 2026 through December 31, 2027. Your prescriber completes a prior authorization, and there are BMI and diagnosis criteria.
The details are in does Medicare cover Wegovy and our Bridge guide. The Bridge eligibility checker walks through the criteria.
What are the side effects of Wegovy?
Most side effects are gastrointestinal. In the adult weight-reduction trials of Wegovy 2.4 mg injection, the label’s table reports nausea in 44 percent of patients (16 percent on placebo), diarrhea in 30 percent (16 percent), vomiting in 24 percent (6 percent), constipation in 24 percent (11 percent) and abdominal pain in 20 percent (10 percent). Overall, 73% of patients on Wegovy injection and 47% on placebo reported a gastrointestinal reaction. The label says these were most frequently reported during dosage escalation, while the dose was going up. In those trials, 6.8% of patients on Wegovy 2.4 mg and 3.2% on placebo stopped treatment permanently because of adverse reactions.
Hair loss appears in the same table at 3 percent with Wegovy 2.4 mg and 1 percent with placebo. For the tablets, the label gives no separate table. It says the types and frequency of common reactions in the 25 mg tablet trial were similar to those of the injection. The incidence tables above show every listed reaction.
The boxed warning
Wegovy carries a boxed warning about thyroid C-cell tumors. In plain words: semaglutide caused thyroid C-cell tumors in rodents, and it’s unknown whether Wegovy causes these tumors, including medullary thyroid carcinoma (MTC), in humans. Because of this, Wegovy is contraindicated, meaning it must not be used, in people with a personal or family history of MTC or with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). It’s also contraindicated after a prior serious hypersensitivity (allergic) reaction to semaglutide or any ingredient.
Other warnings in the label include acute pancreatitis, acute gallbladder disease, low blood sugar (a higher risk with insulin or a sulfonylurea), acute kidney injury from dehydration, severe gastrointestinal reactions, serious allergic reactions, diabetic retinopathy complications in people with type 2 diabetes, an increase in heart rate, and aspiration (stomach contents entering the lungs) during general anesthesia or deep sedation. The label says to tell your healthcare providers that you take Wegovy before any planned surgery or procedure. It also says to stop Wegovy at least 2 months before a planned pregnancy.
Contact a clinician promptly if you have severe or persistent abdominal pain, signs of an allergic reaction, or vomiting and diarrhea that leave you unable to keep fluids down.
What if I miss a dose of Wegovy?
The rule depends on the form.
Injection. If you miss one dose and your next scheduled dose is more than 2 days away, the label says to take the missed dose as soon as possible. If the next scheduled dose is less than 2 days away, don’t take the missed dose, and resume on your regular day. If 2 or more doses in a row are missed, the label says to reinitiate dosage escalation at a lower dosage, meaning you step up again from a lower dose. It doesn’t say which one, so that call belongs to your prescriber.
Tablets. If you miss a dose, skip it and take the next dose the following day.
The missed dose tool applies these rules to your own dates.
How do I store Wegovy?
Pens. Store single-dose pens in the refrigerator at 36°F to 46°F (2°C to 8°C). If needed, before the cap is removed, a pen can be kept between 46°F and 86°F (8°C to 30°C) for up to 28 days. Don’t freeze it, and don’t use a pen that has been frozen. Keep pens in the original carton until you use them, to protect them from light, and throw each pen away after use.
Tablets. Store at room temperature, 68°F to 77°F (20°C to 25°C), in the original bottle, in a dry place. The bottle protects the tablets from moisture, so leave them in it until you take one.
Can I switch between the Wegovy pen and the pill?
The label covers this directly, for adults taking Wegovy for weight reduction or cardiovascular risk reduction. From the 2.4 mg injection, the 25 mg tablet is started one week after the last injection. From the 25 mg tablet, the 2.4 mg weekly injection is started the day after the last tablet. Those are the label’s pairings, not a general conversion, and the change needs a new prescription. The switching planner shows what the labels say for other moves, including to or from Zepbound.
Where to get Wegovy
1. Manufacturer savings card
$25 per fill at 25 mg
Source: wegovy.comGo to the program page
2. Medicare GLP-1 Bridge
$50 per fill at 25 mg
3. NovoCare self-pay
$299 per fill at 25 mg
4. TrumpRx
$299 per fill at 25 mg
5. Ro
$448 per fill at 25 mg
Ranked by cost only. Manufacturer and government programs never pay us. To see every option for your situation, try the cheapest-path quiz.
Frequently asked questions
How much does Wegovy cost without insurance?
If you pay cash through NovoCare Pharmacy, the Wegovy pen costs $349 a month at 1 mg, 1.7 mg and 2.4 mg, and $399 for the 7.2 mg Wegovy HD pen. If you're new to the offer, you pay $199 a month for up to two fills of 0.25 mg or 0.5 mg through December 31, 2026. The list price is $1,349.02 per package.
How much is the Wegovy pill without insurance?
Through NovoCare Pharmacy, the self-pay price for Wegovy tablets is $149 a month for 1.5 mg, $199 for 4 mg, and $299 for 9 mg and 25 mg. A month is one bottle of 30 tablets. Novo Nordisk can change or cancel the offer at any time.
How do you take the Wegovy pill?
The label says to take one tablet once a day, in the morning, on an empty stomach, with up to 4 ounces of plain water and no other liquid. Swallow it whole. Then wait at least 30 minutes before you eat, drink anything else or take other oral medicines. Don't take more than one tablet a day.
Can I take the Wegovy pill at night?
The label gives one timing instruction: take the tablet once daily in the morning on an empty stomach. It doesn't describe an evening or bedtime option. If mornings don't work for you, ask your prescriber or pharmacist. Don't change it on your own.
When do you increase the Wegovy dose?
The injection label steps the dose up every 4 weeks: 0.25 mg for weeks 1 through 4, then 0.5 mg, 1 mg and 1.7 mg for 4 weeks each, reaching 2.4 mg from week 17. If you don't tolerate a dose, the label says to consider delaying the next increase for 4 weeks. Your prescriber decides when you move up.
What is Wegovy 7.2 mg (Wegovy HD)?
Wegovy HD is the 7.2 mg single-dose pen. The label allows it only for weight reduction in adults who have tolerated 2.4 mg for at least 4 weeks and need additional weight reduction. It's the maximum dosage. In clinical trials, dysesthesia (altered skin sensation) was reported in 22% of patients on 7.2 mg, compared with 6% on 2.4 mg.
Does Medicare cover Wegovy?
Medicare Part D doesn't generally cover Wegovy for weight loss alone, but there are two routes. Part D can cover it when it's prescribed to reduce cardiovascular risk in adults with established cardiovascular disease and obesity or overweight. And the Medicare GLP-1 Bridge lets eligible Part D patients get the Wegovy pen or pill for weight management at a $50 monthly copay through December 31, 2027.
What happens if I miss a dose of Wegovy?
For the weekly injection, the label says to take the missed dose as soon as possible if your next scheduled dose is more than 2 days away. If the next dose is less than 2 days away, skip the missed dose. If you miss a daily tablet, skip it and take the next one the following day.
Is Wegovy approved for heart disease?
Yes, for a specific group. The label approves Wegovy injection and tablets to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight. In the outcomes trial of 17,604 adults, the hazard ratio for a first major event was 0.80 for Wegovy injection compared with placebo.
What is Wegovy used for?
The FDA label lists three kinds of use. Wegovy is approved for long-term weight reduction. It's approved to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and obesity or overweight. And the injection only is approved for noncirrhotic MASH with moderate to advanced liver fibrosis in adults.
Is there an oral Wegovy?
Yes. Wegovy tablets, often called the Wegovy pill, are taken once a day in the morning on an empty stomach. They come in strengths of 1.5 mg, 4 mg, 9 mg, 25 mg, and a bottle holds 30 tablets, a 30-day supply. The tablets are approved for adults, not for pediatric patients or for MASH.
Sources (33)
- 1.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“Administer WEGOVY injection once weekly, on the same day each week, at any time of day, with or without meals.”
- 2.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“Inject WEGOVY subcutaneously in the abdomen, thigh, or upper arm. The time of day and the injection site can be changed without the need for a dosage modification.”
- 3.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“Rotate injection sites with each dose.”
- 4.FDA label (DailyMed): Wegovy prescribing information, Medication Guide
“If you need to change the day of the week, you may do so as long as your last dose of WEGOVY was given 2 or more days before.”
- 5.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“Take one WEGOVY tablet orally once daily on an empty stomach in the morning with water (up to 4 ounces). Do not take WEGOVY tablets with other liquids besides water”
- 6.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“After taking a WEGOVY tablet, wait at least 30 minutes before eating food, drinking beverages or taking other oral medications”
- 7.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“Swallow tablets whole. Do not split, crush, chew or dissolve in any solution.”
- 8.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“Do not take more than one tablet per day.”
- 9.FDA label (DailyMed): Wegovy prescribing information, section 2.5
“One week after discontinuing WEGOVY 2.4 mg injection, initiate 25 mg of WEGOVY tablets orally once daily.”
- 10.FDA label (DailyMed): Wegovy prescribing information, section 2.5
“The day after discontinuing WEGOVY tablets 25 mg once daily, initiate WEGOVY 2.4 mg subcutaneous injection once weekly.”
- 11.FDA label (DailyMed): Wegovy prescribing information, section 16
“Store the WEGOVY prefilled single-dose pen or single-dose syringe in the refrigerator from 2°C to 8°C (36°F to 46°F). If needed, prior to the pen or syringe cap removal, the pen can be kept from 8°C to 30°C (46°F to 86°F) up to 28 days.”
- 12.FDA label (DailyMed): Wegovy prescribing information, section 16
“Do not freeze WEGOVY and do not use if it has been frozen.”
- 13.FDA label (DailyMed): Wegovy prescribing information, section 16
“Protect WEGOVY injection from light. WEGOVY injection must be kept in the original carton until time of administration. Discard the WEGOVY pen or syringe after use.”
- 14.FDA label (DailyMed): Wegovy prescribing information, section 16
“Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Store and dispense WEGOVY tablets in the original bottle.”
- 15.FDA label (DailyMed): Wegovy prescribing information, section 16
“Store WEGOVY tablet in the original bottle until use to protect tablets from moisture. Store WEGOVY tablets in a dry place away from moisture.”
- 16.FDA label (DailyMed): Wegovy prescribing information, section 16
“WEGOVY injection is a clear, colorless solution available in cartons containing 4 single-dose pens, 4 single-dose syringes with integrated needles, or 1 single-patient-use pen (WEGOVY FlexTouch) as follows:”
- 17.FDA label (DailyMed): Wegovy prescribing information, Instructions for Use (single-dose pen)
“Your WEGOVY pen is for 1 time use only. The WEGOVY pen is for subcutaneous (under the skin) use only.”
- 18.FDA label (DailyMed): Wegovy prescribing information, section 14.2, Table 8
“After 68 weeks, treatment with WEGOVY injection resulted in a statistically significant reduction in body weight compared with placebo. Greater proportions of patients treated with WEGOVY injection achieved 5%, 10% and 15% weight loss than those treated with placebo as shown in Table 8.”
- 19.FDA label (DailyMed): Wegovy prescribing information, section 14.2, Table 11
“After 64 weeks, treatment with WEGOVY 25 mg tablets resulted in a statistically significant reduction in body weight compared with placebo.”
- 20.FDA label (DailyMed): Wegovy prescribing information, section 14.2, Table 12
“After 72 weeks of treatment, WEGOVY 7.2 mg injection resulted in a statistically significant reduction in body weight compared with placebo in Studies 8 and 9”
- 21.FDA label (DailyMed): Wegovy prescribing information, section 14.1
“WEGOVY injection significantly reduced the risk for first occurrence of MACE. The estimated hazard ratio (95% CI) was 0.80 (0.72, 0.90)”
- 22.FDA label (DailyMed): Wegovy prescribing information, section 14.4, Table 21
“WEGOVY injection demonstrated improvement on these histopathology endpoints at Week 72 compared to placebo.”
- 23.FDA label (DailyMed): Wegovy prescribing information, section 1
“Concomitant use of WEGOVY (semaglutide) tablets or WEGOVY (semaglutide) injection with other semaglutide-containing products or with any other GLP-1 receptor agonist is not recommended.”
- 24.FDA label (DailyMed): Wegovy prescribing information, section 4
“a personal or family history of MTC or in patients with MEN 2”
- 25.FDA label (DailyMed): Wegovy prescribing information, section 4
“a prior serious hypersensitivity reaction to semaglutide or to any of the excipients in WEGOVY injection or WEGOVY tablet. Serious hypersensitivity reactions, including anaphylaxis and angioedema, have been reported with WEGOVY”
- 26.FDA label (DailyMed): Wegovy prescribing information, section 8.3
“Because of the potential for fetal harm, discontinue WEGOVY in patients at least 2 months before they plan to become pregnant to account for the long half-life of semaglutide”
- 27.CMS: BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) Model
“GLP-1 drugs for weight loss, along with lifestyle interventions, can help people improve their overall health, but GLP-1s are expensive and currently Medicare and Medicaid generally do not cover these drugs for the weight loss indication.”
- 28.CMS: Information for Part D Plans
“Beneficiaries who are prescribed an eligible GLP-1 drug for a use that is coverable under the basic Medicare Part D benefit, regardless of whether the eligible GLP-1 drug is on the Part D plan’s formulary (e.g., Zepbound® for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity; Wegovy® to reduce the risk of major adverse cardiovascular (CV) events in adults with established CV disease and either obesity or overweight) would not qualify for coverage of that eligible GLP-1 drug under the Medicare GLP-1 Bridge. Part D plan sponsors must continue to follow their existing formulary exception processes for these requests.”
- 29.CMS: Information for Part D Plans
“Type 2 diabetes, moderate to severe obstructive sleep apnea, and noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis) indications are eligible for Part D coverage. [...] If a Medicare Part D beneficiary has a prescription for a GLP-1 drug for an indication covered under Medicare Part D, they should continue to obtain their GLP-1 through their Part D plan.”
- 30.
- 31.
- 32.
- 33.
Related pages
- Wegovy cost: pen and pill prices with and without insurance
- What is Ozempic? Uses, doses, cost and how to take it
- What is Zepbound? Uses, cost, doses and side effects
- Cost calculator
- Wegovy for heart disease: the approved use, the trial behind it and who pays
- Wegovy for MASH: what is approved, what the trial showed and who covers it
